Mediterranean Diet Rewires the Body’s Immune Clock in Obesity, Study Finds

A twelve-week Mediterranean diet does far more than shrink waistlines, according to a new study from researchers at Federico II University of Naples. In a prospective exploratory interventional trial published in the Journal of Translational Medicine, the team reports that a hypocaloric Mediterranean dietary intervention was associated with measurable changes in the daily rhythm of clock genes and innate immune receptors circulating in immune cells of patients with obesity. The findings, the authors suggest, point to a previously underappreciated mechanism by which food may restore the delicate molecular dialogue between the body’s internal clock and its inflammatory defenses.

Obesity has long been recognized as a state of chronic low-grade inflammation, a smoldering immune activation that contributes to insulin resistance, fatty liver disease, and cardiovascular risk. At the same time, obesity is marked by circadian disruption: the molecular clocks that orchestrate daily cycles of metabolism, hormone secretion, and immune activity fall out of sync. What has remained unclear is whether these two phenomena are merely parallel consequences of excess weight or whether they are mechanistically intertwined, and, crucially, whether a dietary intervention can pull both back into alignment at the same time.

The new study, led by Claudia Pivonello and senior author Annamaria Colao, set out to address exactly that question. Thirty-eight adults with obesity completed a twelve-week hypocaloric Mediterranean diet program. Before and after the intervention, the researchers collected detailed anthropometric and metabolic measurements, including body weight, body mass index, waist circumference, fat mass percentage, fat-free mass, muscle mass, and HDL cholesterol. They also assessed each participant’s chronotype using the Morningness–Eveningness Questionnaire, a validated instrument that captures whether a person’s natural tendencies lean toward morning or evening activity.

The most technically ambitious part of the study involved the participants’ peripheral blood mononuclear cells, or PBMCs, a mixed population of immune cells that includes lymphocytes and monocytes. Blood samples were drawn at two fixed time points, eight in the morning and four in the afternoon, allowing the researchers to track how gene expression shifted across the day. Using quantitative reverse-transcription PCR, they measured the expression of five core clock genes: BMAL1, PER1, PER2, CRY1, and CRY2. These genes form the interlocking feedback loops that constitute the molecular circadian oscillator, with BMAL1 acting as the positive driving element and the PER and CRY proteins as the negative limbs that restrain its activity on a roughly twenty-four-hour cycle. Alongside the clock genes, the team quantified expression of two innate immune receptors, TLR4 and TLR8, members of the Toll-like receptor family that detect microbial components and trigger inflammatory signaling.

The metabolic results were consistent with what clinicians have come to expect from a well-executed Mediterranean diet intervention. Participants showed significant reductions in body weight, body mass index, waist circumference, and fat mass percentage, together with increases in fat-free mass, muscle mass, and HDL cholesterol. Their MEQ scores also rose significantly, indicating a shift toward greater morningness, although the distribution of chronotype categories did not change in a statistically significant way. In other words, participants drifted somewhat toward morning preference without crossing into a new chronotype classification.

The molecular findings were more striking. At baseline, before any dietary change, expression of TLR4 and TLR8 in PBMCs was significantly higher in the afternoon than in the morning, a diurnal pattern in innate immune receptor expression that the researchers documented for the first time in this cohort. After twelve weeks of the Mediterranean diet, the picture had changed in a coordinated fashion. BMAL1 expression increased significantly in the morning samples, while PER1, TLR4, and TLR8 expression decreased significantly in the afternoon samples. Moreover, all five clock genes examined, BMAL1, PER1, PER2, CRY1, and CRY2, displayed a more pronounced morning-to-afternoon expression pattern following the intervention, which the authors interpret as evidence of improved diurnal organization of the peripheral clock.

Perhaps the most intriguing observation was the correlation structure linking the two systems. The researchers found significant positive correlations between BMAL1 expression and both TLR4 and TLR8 expression at both sampling time points. This statistical relationship supports the hypothesis of a bidirectional interaction between the molecular clock and innate immune pathways, a connection that has been suggested by animal and cellular studies but rarely examined in the context of a human dietary intervention. If BMAL1 activity helps govern the daily rhythm of Toll-like receptor expression, then dietary signals that strengthen the clock could, in principle, dampen the inappropriate immune activation that characterizes obesity.

The authors frame their results as evidence of partial restoration of diurnal–immune homeostasis. Increased morning BMAL1 together with reduced afternoon TLR4 and TLR8 suggests that the intervention did not simply suppress inflammation indiscriminately but instead rebalanced the temporal architecture of immune readiness. They propose that dietary modulation of what they call the BMAL1–TLR axis may represent a mechanism linking metabolic improvement to diurnal regulation, and they identify peripheral clock gene expression as a potential translational biomarker of response to lifestyle interventions. If validated, such a biomarker could allow clinicians to monitor, at the level of gene expression in a simple blood draw, whether a patient’s body clock and immune system are responding to dietary therapy.

Important caveats temper these conclusions. The study lacked a comparator arm, meaning there was no control group of patients with obesity who did not receive the intervention or who received an alternative diet. Without such a group, the findings must be interpreted as associations rather than proof of causation, and the authors are explicit on this point, calling for confirmation in randomized controlled studies. The sample size of thirty-eight participants, while adequate for an exploratory interventional design, is modest, and the two-time-point sampling strategy captures only a coarse snapshot of the full twenty-four-hour rhythm. The study was registered at ClinicalTrials.gov as NCT06236932 and was approved by the Ethical Committee of Federico II University of Naples, and it was funded by the Italian Ministry of University and Research through a Projects of Relevant National Interest grant.

Even with those limitations, the study adds a compelling piece to a rapidly growing body of work on the circadian–immune axis. It suggests that the Mediterranean diet, already celebrated for its cardiovascular and metabolic benefits, may exert part of its influence by entraining the peripheral clocks embedded in immune cells and by smoothing out the aberrant daily oscillations of innate immune receptors. For patients with obesity, the practical message is familiar but now carries deeper mechanistic weight: what you eat, and presumably when you eat it, may help decide not only how much you weigh but how well your body’s internal timekeeping and immune surveillance work together. For researchers, the message is that the blood-borne clock may be a readable, and potentially modifiable, target of nutritional therapy.

Subject of Research: Effects of a hypocaloric Mediterranean diet on circadian clock gene and innate immune receptor expression in patients with obesity

Article Title: A 12-week hypocaloric Mediterranean diet is associated with metabolic improvement and modulation of diurnal clock gene and innate immune receptor expression in peripheral blood mononuclear cells of patients with obesity

Article References: Pivonello, C., Magnacca, N., Graziadio, C., Negri, M., Vetrani, C., Amatrudo, F., Vozza, E., Vecchio, G. D., Tini, S., Celano, S., Prodam, F., Auriemma, R. S., Pivonello, R., & Colao, A. (2026). A 12-week hypocaloric Mediterranean diet is associated with metabolic improvement and modulation of diurnal clock gene and innate immune receptor expression in peripheral blood mononuclear cells of patients with obesity. Journal of Translational Medicine. https://doi.org/10.1186/s12967-026-09013-0

Image Credits: AI Generated

DOI: 10.1186/s12967-026-09013-0

Keywords: Mediterranean diet, obesity, circadian rhythm, clock genes, BMAL1, Toll-like receptors, TLR4, TLR8, peripheral blood mononuclear cells, inflammation, chronotype, nutritional intervention